FDA Inspection 931632 — Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd.
The FDA completed an inspection of Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. on May 22, 2015 in Wuhan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 22, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wuhan (China)